A clinical trial has found that giving peanut oral immunotherapy to highly peanut-allergic children ages 1 to 3 years safely desensitized most of them to peanut and induced remission of peanut allergy in one-fifth.
from Top Health News -- ScienceDaily https://ift.tt/3GWVJqg
Post a Comment